Koyfin Home > Directory > Health Care > Aimmune Therap > Cash from Investing Activities

Aimmune Therap Cash from Investing Activities Chart (AIMT)

Aimmune Therap annual/quarterly Cash from Investing Activities from 2014 to 2020.
  • Aimmune Therap Cash from Investing Activities for the quarter ending June 06, 2020 was $21m a -145.29% decrease of -31m year over year
  • Aimmune Therap Cash from Investing Activities for the last 12 months ending June 06, 2020 was $123m a 61.63% increase of 76m year over year
  • Aimmune Therap Annual Cash from Investing Activities for 2019 was $112m a 185.80% increase of 208m from 2018
  • Aimmune Therap Annual Cash from Investing Activities for 2018 was $-96m a 144.33% decrease of -139m from 2017
  • Aimmune Therap Annual Cash from Investing Activities for 2017 was $43m a 203.13% increase of 86m from 2016
Other Cash Flow Metrics:
  • Aimmune Therap Cash Flow from Operations for the quarter ending September 09, 2018 was $-41m a 22.62% decrease of -9m year over year
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a 30.11% decrease of -7m year over year
View Chart On Koyfin

Quarterly AIMT Cash from Investing Activities Data

06/2020$21m
03/2020$5m
12/2019$44m
09/2019$52m
06/2019$35m
03/2019$-20m
12/2018$-20m
09/2018$-25m
06/2018$-35m
03/2018$-16m

Annual AIMT Cash from Investing Activities Data

2019$112m
2018$-96m
2017$43m
2016$-44m
2015$-125m
2014$0m
2013$0m